TP53 and cancer: The influence of mutant p53 in the clinical outcome of cancer patients, the high frequency of GOF mutations in the TP53 gene, and the involvement of mutant p53 in a number of different cellular pathways have stressed the need to deeply investigate the events that are associated to cancer progression driven by mutant p53 isoforms in molecular oncology.